According to Travere Therapeutics's latest financial reports the company's current EPS (TTM) is -4,30ย โฌ. In 2022 the company made an earnings per share (EPS) of -4,16ย โฌ a decrease over its 2021 EPS that were of -2,89ย โฌ.